These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3225412)

  • 1. Prostaglandins influence myofibroblast contractility in Dupuytren's disease.
    Badalamente MA; Hurst LC; Sampson SP
    J Hand Surg Am; 1988 Nov; 13(6):867-71. PubMed ID: 3225412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathobiology of Dupuytren's contracture: effects of prostaglandins on myofibroblasts.
    Hurst LC; Badalamente MA; Makowski J
    J Hand Surg Am; 1986 Jan; 11(1):18-23. PubMed ID: 3456001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic regulation of Dupuytren's fibroblast contraction in vitro.
    Rayan GM; Parizi M; Tomasek JJ
    J Hand Surg Am; 1996 Nov; 21(6):1065-70. PubMed ID: 8969433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells.
    Verjee LS; Midwood K; Davidson D; Eastwood M; Nanchahal J
    J Cell Physiol; 2010 Sep; 224(3):681-90. PubMed ID: 20432463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
    Tomasek J; Rayan GM
    J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of contractile force by cultured Dupuytren's disease and normal palmar fibroblasts.
    Rayan GM; Tomasek JJ
    Tissue Cell; 1994 Oct; 26(5):747-56. PubMed ID: 9437248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation.
    Jemec B; Linge C; Grobbelaar AO; Smith PJ; Sanders R; McGrouther DA
    Chir Main; 2000 Feb; 19(1):15-22. PubMed ID: 10777424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose-derived stem cells inhibit the contractile myofibroblast in Dupuytren's disease.
    Verhoekx JSN; Mudera V; Walbeehm ET; Hovius SER
    Plast Reconstr Surg; 2013 Nov; 132(5):1139-1148. PubMed ID: 23924646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dupuytren's fibroblast contractility by sphingosine-1-phosphate is mediated through non-muscle myosin II.
    Komatsu I; Bond J; Selim A; Tomasek JJ; Levin LS; Levinson H
    J Hand Surg Am; 2010 Oct; 35(10):1580-8. PubMed ID: 20888494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular structure and biology of Dupuytren's disease.
    Tomasek JJ; Vaughan MB; Haaksma CJ
    Hand Clin; 1999 Feb; 15(1):21-34. PubMed ID: 10050239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The myofibroblast in Dupuytren's contracture.
    Rudolph R; Vande Berg J
    Hand Clin; 1991 Nov; 7(4):683-92; discussion 693-4. PubMed ID: 1769990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target.
    Verjee LS; Verhoekx JS; Chan JK; Krausgruber T; Nicolaidou V; Izadi D; Davidson D; Feldmann M; Midwood KS; Nanchahal J
    Proc Natl Acad Sci U S A; 2013 Mar; 110(10):E928-37. PubMed ID: 23431165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
    J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dupuytren's disease susceptibility gene, EPDR1, is involved in myofibroblast contractility.
    Staats KA; Wu T; Gan BS; O'Gorman DB; Ophoff RA
    J Dermatol Sci; 2016 Aug; 83(2):131-7. PubMed ID: 27245865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis of Dupuytren's contracture: contractile mechanisms of the myofibroblasts.
    Badalamente MA; Stern L; Hurst LC
    J Hand Surg Am; 1983 May; 8(3):235-43. PubMed ID: 6683733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
    Dave SA; Banducci DR; Graham WP; Allison GM; Ehrlich HP
    Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness of Dupuytren's disease fibroblasts to 5 alpha-dihydrotestosterone.
    Pagnotta A; Specchia N; Soccetti A; Manzotti S; Greco F
    J Hand Surg Am; 2003 Nov; 28(6):1029-34. PubMed ID: 14642522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptors in Dupuytren's contracture.
    Pagnotta A; Specchia N; Greco F
    J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biochemistry of Dupuytren's disease.
    Badalamente MA; Hurst LC
    Hand Clin; 1999 Feb; 15(1):35-42, v-vi. PubMed ID: 10050240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.